Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer

References

• Akaishi, T., Morimoto, T., Shibao, M., Watanabe, S., Sakai-Kato, K., & Abe, K. (2008). Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein. Neuroscience Letters, 444, 280–285.
   PubMed Web of Science ®Google Scholar
• Armstrong, A. H., Chen, J., McKoy, A. F., & Hecht, M. H. (2011). Mutations That replace aromatic side chains promote aggregation of the Alzheimer’s a beta peptide. Biochemistry, 50, 4058–4067.10.1021/bi200268w
   PubMed Web of Science ®Google Scholar
• Bastianetto, S., Krantic, S., & Quirion, R. (2008). Polyphenols as potential inhibitors of amyloid aggregation and toxicity: Possible significance to Alzheimer’s disease. Mini-reviews in Medicinal Chemistry, 8, 429–435.
   PubMed Web of Science ®Google Scholar
• von Bergen, P. F. M., Biernat, P., Heberle, J., Mandelkow, E.-M., & Mandelkow, E. (2000). Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure. Proceedings of the National Academy of Sciences, 97, 5129–5134.10.1073/pnas.97.10.5129
   PubMed Web of Science ®Google Scholar
• Berhanu, W. M., & Masunov, A. E. (2010). Natural polyphenols as inhibitors of amyloid aggregation. Molecular dynamics study of GNNQQNY heptapeptide decamer. Biophysical Chemistry, 149, 12–21.10.1016/j.bpc.2010.03.003
   PubMed Web of Science ®Google Scholar
• Berhanu, W. M., & Masunov, A. E. (2011a). Can molecular dynamics simulations assist in design of specific inhibitors and imaging agents of amyloid aggregation? Structure, stability and free energy predictions for amyloid oligomers of VQIVYK, MVGGVV and LYQLEN. Journal of Molecular Modeling, 17, 2423–2442.10.1007/s00894-010-0912-4
   PubMed Web of Science ®Google Scholar
• Berhanu, W. M., & Masunov, A. E. (2011b). Molecular dynamic simulation of wild type and mutants of the polymorphic amyloid NNQNTF segments of Elk prion: Structural stability and thermodynamic of association. Biopolymers, 95, 573–590.10.1002/bip.v95.9
   PubMed Web of Science ®Google Scholar
• Berhanu, W. M., & Masunov, A. E. (2012a). Alternative packing modes leading to amyloid polymorphism in five fragments studied with molecular dynamics. Biopolymers, 98, 131–144.10.1002/bip.v98.2
   PubMed Web of Science ®Google Scholar
• Berhanu, W. M., & Masunov, A. E. (2012b). Controlling the aggregation and rate of release in order to improve insulin formulation: Molecular dynamics study of full-length insulin amyloid oligomer models. Journal of Molecular Modeling, 18, 1129–1142.10.1007/s00894-011-1123-3
   PubMed Web of Science ®Google Scholar
• Berhanu, W. M., & Masunov, A. E. (2012c). Unique example of amyloid aggregates stabilized by main chain H-bond instead of the steric zipper: Molecular dynamics study of the amyloidogenic segment of amylin wild-type and mutants. Journal of Molecular Modeling, 18, 891–903.10.1007/s00894-011-1030-7
   PubMed Web of Science ®Google Scholar
• Berhanu, W. M., & Masunov, A. E. (2013). The atomic level interaction of polyphenols with the amyloid oligomer aggregate, a molecular dynamic guidance for rational drug design. In R. R. Watson (Ed.), Polyphenols in human health and disease (pp. 59–70). Oxford: Academic Press.
   Google Scholar
• Berhanu, W. M., & Masunov, A. E. (2014). Full length amylin oligomer aggregation: Insights from molecular dynamics simulations and implications for design of aggregation inhibitors. Journal of Biomolecular Structure & Dynamics, 32, 1651–1669.
   PubMed Web of Science ®Google Scholar
• Cardenas-Jiron, G. I., Masunov, A., & Dannenberg, J. J. (1999). Molecular orbital study of crystalline p-benzoquinone. Journal of Physical Chemistry A, 103, 7042–7046.
   Web of Science ®Google Scholar
• Case, D. A., Darden, T. A., Cheatham, I., Simmerling, T. E. Wang, C., Duke, J., … Kollman, P. A. (2010). AMBER 11. San Francisco, CA: University of California San Francisco.
   Google Scholar
• Chen, Y., He, Y. J., Wu, M. Y., Yan, G. W., Li, Y. X., Zhang, J., & Chen, H. F. (2010). Insight into the stability of cross-beta amyloid fibril from molecular dynamics simulation. Biopolymers, 93, 578–586.
   PubMed Web of Science ®Google Scholar
• Chiti, F., & Dobson, C. M. (2006). Protein misfolding, functional amyloid, and human disease. Annual Review of Biochemistry, 75, 333–366.10.1146/annurev.biochem.75.101304.123901
   PubMed Web of Science ®Google Scholar
• Convertino, M., Pellarin, R., Catto, M., Carotti, A., & Caflisch, A. (2009). 9,10-Anthraquinone hinders beta-aggregation: How does a small molecule interfere with A beta-peptide amyloid fibrillation? Protein Science, 18, 792–800.
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald – An n.log(n) method for Ewald sums in large systems. Journal of Chemical Physics, 98, 10089–10092.
   Web of Science ®Google Scholar
• De Simone, A., Esposito, L., Pedone, C., & Vitagliano, L. (2008). Insights into stability and toxicity of amyloid-like oligomers by replica exchange molecular dynamics analyses. Biophysical Journal, 95, 1965–1973.10.1529/biophysj.108.129213
   PubMed Web of Science ®Google Scholar
• Fabiola, F., Bertram, R., Korostelev, A., & Chapman, M. S. (2002). An improved hydrogen bond potential: Impact on medium resolution protein structures. Protein Science, 11, 1415–1423.10.1110/ps.4890102
   PubMed Web of Science ®Google Scholar
• Frisch M. J. T., G. W, Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Montgomery, J. A., Jr, … Pople, J. A. (2004). Gaussian 03. Wallingford CT: Gaussian Inc.
   Google Scholar
• Gilson, M. K., & Zhou, H. X. (2007). Calculation of protein-ligand binding affinities. Annual Review of Biophysics and Biomolecular Structure, 36, 21–42.
   PubMedGoogle Scholar
• Gohlke, H., Kiel, C., & Case, D. A. (2003). Insights into Protein–Protein binding by binding free energy calculation and free energy decomposition for the Ras–Raf and Ras–RalGDS complexes. Journal of Molecular Biology, 330, 891–913.10.1016/S0022-2836(03)00610-7
   PubMed Web of Science ®Google Scholar
• Gutierrez, L. J., Enriz, R. D., & Baldoni, H. A. (2010). Structural and thermodynamic characteristics of the exosite binding pocket on the human BACE1: A molecular modeling approach. Journal of Physical Chemistry A, 114, 10261–10269.
   PubMed Web of Science ®Google Scholar
• He, J., Xing, Y. F., Huang, B., Zhang, Y. Z., & Zeng, C. M. (2009). Tea catechins induce the conversion of preformed lysozyme amyloid fibrils to amorphous aggregates. Journal of Agricultural and Food Chemistry, 57, 11391–11396.10.1021/jf902664f
   PubMed Web of Science ®Google Scholar
• Ho, L., & Pasinetti, G. M. (2010). Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding. Expert Review of Proteomics, 7, 579–589.10.1586/epr.10.69
   PubMed Web of Science ®Google Scholar
• Ho, L., Yemul, S., Wang, J., & Pasinettia, G. M. (2009). Grape seed polyphenolic extract as a potential novel therapeutic agent in tauopathies. Journal of Alzheimers Disease, 16, 433–439.
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14, 33–38.10.1016/0263-7855(96)00018-5
   PubMed Web of Science ®Google Scholar
• Kim, H., Park, B. S., Lee, K. G., Choi, C. Y., Jang, S. S., Kim, Y. H., & Lee, S. E. (2005). Effects of naturally occurring compounds on fibril formation and oxidative stress of β-amyloid. Journal of Agricultural and Food Chemistry, 53, 8537–8541.10.1021/jf051985c
   PubMed Web of Science ®Google Scholar
• Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S. H., Chong, L., … Cheatham, T. E. (2000). Calculating structures and free energies of complex molecules:  Combining molecular mechanics and continuum models. Accounts of Chemical Research, 33, 889–897.10.1021/ar000033j
   PubMed Web of Science ®Google Scholar
• Kuchma, M. H., Komanski, C. B., Colon, J., Teblum, A., Masunov, A. E., Seal, S., … Baker, C. H. (2010). Phosphate ester hydrolysis of biologically relevant molecules by cerium oxide nanoparticles. Nanomedicine-Nanotechnology Biology and Medicine, 6, 738–744.
   PubMed Web of Science ®Google Scholar
• Landau, M., Sawaya, M. R., Faull, K. F., Laganowsky, A., Jiang, L., Sievers, S. A., … Eisenberg, D. (2011). Towards a pharmacophore for amyloid. PLoS Biology, 9, Article Number, e1001080.
   PubMed Web of Science ®Google Scholar
• Lemkul, J. A., & Bevan, D. R. (2010). Destabilizing Alzheimer’s Aβ 42 protofibrils with Morin: Mechanistic insights from molecular dynamics simulations. Biochemistry, 49, 3935–3946.10.1021/bi1000855
   PubMed Web of Science ®Google Scholar
• Leonidov, N. B., Zorkii, P. M., Masunov, A. E., Gladkikh, O. P., Belskii, V. K., Dzyabchenko, A. V., & Ivanov, S. A. (1993). Structure and biononequivalence of methyluracyl polymorphous forms. Zhurnal Fizicheskoi Khimii, 67, 2464–2468.
   Google Scholar
• Li, D. W., Mohanty, S., Irback, A., & Huo, S. H. (2008). Formation and growth of oligomers: A Monte Carlo study of an amyloid tau fragment. PLoS Computational Biology, 9, e1000238.
   Web of Science ®Google Scholar
• Massova, I., & Kollman, P. A. (1999). Computational alanine scanning to probe protein−protein interactions:  A novel approach to evaluate binding free energies. Journal of the American Chemical Society, 121, 8133–8143.10.1021/ja990935j
   Web of Science ®Google Scholar
• Masuda, M., Suzuki, N., Taniguchi, S., Oikawa, T., Nonaka, T., Iwatsubo, T., … Hasegawa, M.(2006). Small molecule inhibitors of α-synuclein filament assembly. Biochemistry, 45, 6085–6094.10.1021/bi0600749
   PubMed Web of Science ®Google Scholar
• Masunov, A. E., & Zorkii, P. M. (1992). Geometric characteristics of halogen-halogen intermolecular contacts in organic-crystals. Zhurnal Fizicheskoi Khimii, 66, 60–69.
   Google Scholar
• Mikhailov, I. A., Belfield, K. D., & Masunov, A. E. (2009). DFT-based methods in the design of two-photon operated molecular switches. Journal of Physical Chemistry A, 113, 7080–7089.
   PubMed Web of Science ®Google Scholar
• Masunov, A. E., Grishchenko, S. I., & Zorkii, P. M. (1993). Effect of specific intermolecular interactions on crystalline-structure – Uracyl derivatives and analogs. Zhurnal Fizicheskoi Khimii, 67, 221–239.
   Google Scholar
• Miyamoto, S., & Kollman, P. A. (1993). What determines the strength of noncovalent association of ligands to proteins in aqueous-solution, in. Proceedings of the National academy of Sciences of the United States of America, 90, 8402–8406.
   PubMed Web of Science ®Google Scholar
• Nishiura, C., Takeuchi, K., Minoura, K., Sumida, M., Taniguchi, T., Tomoo, K., & Ishida, T. (2010). Importance of Tyr310 residue in the third repeat of microtubule binding domain for filament formation of tau protein. Journal of Biochemistry, 147, 405–414.10.1093/jb/mvp181
   PubMed Web of Science ®Google Scholar
• Ono, K., & Yamada, M. (2006). Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. Journal of Neurochemistry, 97, 105–115.10.1111/jnc.2006.97.issue-1
   PubMed Web of Science ®Google Scholar
• Plumley, J. A., & Dannenberg, J. J. (2010). The importance of hydrogen bonding between the glutamine side chains to the formation of amyloid VQIVYK parallel β-sheets: An ONIOM DFT/AM1 Study. Journal of the American Chemical Society, 132, 1758–1759.10.1021/ja909690a
   PubMed Web of Science ®Google Scholar
• Plumley, J. A., & Dannenberg, J. J. (2011). Comparison of beta-sheets of capped polyalanine with those of the tau-amyloid structures VQIVYK and VQIINK. A density functional theory study. Journal of Physical Chemistry B, 115, 10560–10566.
   PubMed Web of Science ®Google Scholar
• Porat, Y., et al. (2006). Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism. Chemical Biology & Drug Design, 67, 27–37.
   PubMed Web of Science ®Google Scholar
• Raman, E. P., Takeda, T., & Klimov, D. K. (2009). Molecular dynamics simulations of ibuprofen binding to a β peptides. Biophysical Journal, 97, 2070–2079.10.1016/j.bpj.2009.07.032
   PubMed Web of Science ®Google Scholar
• Ryckaert, J. P., Ciccotti, G., & Berendsen, H. J. C. (1977). Numerical-integration of cartesian equations of motion of a system with constraints – Molecular-dynamics of n-alkanes. Journal of Computational Physics, 23, 327–341.
   Web of Science ®Google Scholar
• Sawaya, M. R., Sambashivan, S., Nelson, R., Ivanova, M. I., Sievers, S. A., Apostol, M. I., … Eisenberg, D. (2007). Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature, 447, 453–457.10.1038/nature05695
   PubMed Web of Science ®Google Scholar
• Shoval, H., Lichtenberg, D., & Gazit, E. (2007). The molecular mechanisms of the anti-amyloid effects of phenols. Amyloid-Journal of Protein Folding Disorders, 14, 73–87.10.1080/13506120601116674
   PubMed Web of Science ®Google Scholar
• Takeda, T., Chang, W. L. E., Raman, E. P., & Klimov, D. K. (2010). Binding of nonsteroidal anti-inflammatory drugs to a β fibril. Proteins-Structure Function and Bioinformatics, 78, 2849–2860.10.1002/prot.v78:13
   PubMed Web of Science ®Google Scholar
• Taniguchi, S., Suzuki, N., Masuda, M., Hisanaga, S., Iwatsubo, T., Goedert, M., & Hasegawa, M. (2005). Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. Journal of Biological Chemistry, 280, 7614–7623.
   PubMed Web of Science ®Google Scholar
• Toro, C., Thibert, A., De Boni, L., Masunov, A. E., & Hernandez, F. E. (2008). Fluorescence emission of disperse red 1 in solution at room temperature. Journal of Physical Chemistry B, 112, 929–937.
   PubMed Web of Science ®Google Scholar
• Vitagliano, L., Stanzione, F., De Simone, A., & Esposito, L. (2009). Dynamics and stability of amyloid-like steric zipper assemblies with hydrophobic dry interfaces. Biopolymers, 91, 1161–1171.
   PubMed Web of Science ®Google Scholar
• Wang, J. M., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25, 1157–1174.10.1002/(ISSN)1096-987X
   PubMed Web of Science ®Google Scholar
• Wang, J., Santa-Maria, I., Ho, L., Ksiezak-Reding, H., Ono, K., Teplow, D. B., & Pasinetti, G. M. (2010). Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer’s disease. Journal of Alzheimers Disease, 22, 653–661.
   PubMed Web of Science ®Google Scholar
• Wiltzius, J. J. W., Landau, M., Nelson, R., Sawaya, M. R., Apostol, M. I., Goldschmidt, L., … Eisenberg, D. (2009). Molecular mechanisms for protein-encoded inheritance. Nature Structural & Molecular Biology, 16, 973–978.
   PubMed Web of Science ®Google Scholar
• Wu, C., Wang, Z. X., Lei, H. X., Zhang, W., & Duan, Y. (2007). Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations. Journal of the American Chemical Society, 129, 1225–1232.
   PubMed Web of Science ®Google Scholar
• Wu, C., Wang, Z. X., Lei, H. X., Duan, Y., Bowers, M. T., & Shea, J. E. (2008). The binding of thioflavin T and its neutral analog BTA-1 to protofibrils of the Alzheimer’s disease Aβ16–22 peptide probed by molecular dynamics simulations. Journal of Molecular Biology, 384, 718–729.10.1016/j.jmb.2008.09.062
   PubMed Web of Science ®Google Scholar
• Yanagisawa, D., Shirai, N., Amatsubo, T., Taguchi, H., Hirao, K., Urushitani, M., … Tooyama, I. (2010). Relationship between the tautomeric structures of curcumin derivatives and their Aβ-binding activities in the context of therapies for Alzheimer's disease. Biomaterials, 31, 4179–4185.10.1016/j.biomaterials.2010.01.142
   PubMed Web of Science ®Google Scholar
• Yang, F. S., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., … Cole, G. M. (2005). Curcumin inhibits formation of amyloid oligomers and fibrils, binds plaques, and reduces amyloid in vivo. Journal of Biological Chemistry, 280, 5892–5901.10.1074/jbc.M404751200
   PubMed Web of Science ®Google Scholar
• Zhu, M., Rajamani, S., Kaylor, J., Han, S., Zhou, F. M., & Fink, A. L. (2004). The flavonoid baicalein inhibits fibrillation of synuclein and disaggregates existing fibrils. Journal of Biological Chemistry, 279, 26846–26857.10.1074/jbc.M403129200
   PubMed Web of Science ®Google Scholar
• Zhu, J. T. T., Choi, R. C. Y., Chu, G. K. Y., Cheung, A. W. H., Gao, Q. T., Li, J., … Tsim, K. W. K. (2007). Flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: A comparison of different flavonoids in activating estrogenic effect and in preventing β-amyloid-induced cell death. Journal of Agricultural and Food Chemistry, 55, 2438–2445.10.1021/jf063299z
   PubMed Web of Science ®Google Scholar